Application of MIDD in Clinical Research of Antitumor Drugs by Mengyang YU, Hongyun WANG

Subjects: “…model-informed drug development…”
Get full text

Editorial: Model-informed drug development and evidence-based translational pharmacology by Jinxin Zhao, Xiao Zhu, Songwen Tan, Chuanpin Chen, Amal Kaddoumi, Xiu-Li Guo, Yu-Wei Lin, Yu-Wei Lin, Yu-Wei Lin, Yu-Wei Lin, S. Y. Amy Cheung

Subjects: “…model informed drug development…”
Get full text

Optimization of Personalized Amlodipine Dosing Strategies for Children Based on Pharmacokinetic Data from Chinese Male Adults and PBPK Modeling by Xiaolu Han, Xiaoxuan Hong, Xianfu Li, Yuxi Wang, Zengming Wang, Aiping Zheng

Subjects: Get full text

Model-informed drug development of novel ROCK2 inhibitor TDI01: population pharmacokinetic study and simulation by Xiwei Ji, Yimin Cui

Subjects: Get full text

Demystifying physiologically based pharmacokinetic modelling among non-modelers towards model-informed medicine use in under-served populations. [version 1; peer review: 3 approved... by Jolien Freriksen, Susan Cole, Joyce van der Heijden, Karen R Yeo, Trevor Johnson, Essam Kerwash, Marika de Hoop-Sommen, Rick Greupink, Janet Nooney, Saskia de Wildt, Ping Zhao

Subjects: Get full text

PBPK-based dose finding for sildenafil in pregnant women for antenatal treatment of congenital diaphragmatic hernia by Julia Macente, Nina Nauwelaerts, Francesca M. Russo, Jan Deprest, Karel Allegaert, Karel Allegaert, Karel Allegaert, Bart Lammens, Rodolfo Hernandes Bonan, Jessica M. Turner, Sailesh Kumar, Andrea Diniz, Frederico S. Martins, Pieter Annaert, Pieter Annaert

Subjects: Get full text

Regulatory Considerations for the Mother, Fetus and Neonate in Fetal Pharmacology Modeling by Dionna J. Green, Kyunghun Park, Varsha Bhatt-Mehta, Donna Snyder, Gilbert J. Burckart

Subjects: Get full text

Model-Informed Optimization of a Pediatric Clinical Pharmacokinetic Trial of a New Spironolactone Liquid Formulation by Manasa Tatipalli, Vijay Kumar Siripuram, Tao Long, Diana Shuster, Galina Bernstein, Pierre Martineau, Kim A. Cook, Rodrigo Cristofoletti, Stephan Schmidt, Valvanera Vozmediano

Subjects: Get full text

Pediatric oncology drug development and dosage optimization by S. Y. Amy Cheung, Justin L. Hay, Yu-Wei Lin, Rik de Greef, Julie Bullock

Subjects: Get full text

Flat dose regimen of toripalimab based on model-informed drug development approach by Lili Li, Jianye Qu, Ming Song, Qun Zhao, Yonghua Yang, Xi Tan, Yanyan Hu, Jing Li, Yunfei Lin, Hui Feng, Hui Feng, Sheng Yao, Sheng Yao, Patricia Keegan, Meixia Chen

Subjects: Get full text

Editorial: Model-informed drug development and precision dosing in clinical pharmacology practice by Ke Hu, Meng Fu, Xueting Huang, Sumei He, Zheng Jiao, Dongdong Wang

Subjects: “…model-informed drug development…”
Get full text

Model-Informed Drug Development: In Silico Assessment of Drug Bioperformance following Oral and Percutaneous Administration by Jelena Djuris, Sandra Cvijic, Ljiljana Djekic

Subjects: “…model-informed drug development…”
Get full text

Model-Informed Drug Development of New Cefoperazone Sodium and Sulbactam Sodium Combination (3:1): Pharmacokinetic/Pharmacodynamic Analysis and Antibacterial Efficacy Against Enter... by Xi-Wei Ji, Xiao Zhu, Yun Li, Feng Xue, Isabelle Hui San Kuan, Isabelle Hui San Kuan, Qing-Feng He, Xiang-Rui Meng, Xiao-Qiang Xiang, Yi-Min Cui, Bo Zheng

Subjects: Get full text

Mathematical modeling in autoimmune diseases: from theory to clinical application by Yaroslav Ugolkov, Yaroslav Ugolkov, Yaroslav Ugolkov, Antonina Nikitich, Antonina Nikitich, Cristina Leon, Gabriel Helmlinger, Kirill Peskov, Kirill Peskov, Kirill Peskov, Kirill Peskov, Victor Sokolov, Victor Sokolov, Alina Volkova, Alina Volkova

Subjects: Get full text

Model-Informed Repurposing of Medicines for SARS-CoV-2: Extrapolation of Antiviral Activity and Dose Rationale for Paediatric Patients by Federico Romano, Salvatore D’Agate, Oscar Della Pasqua

Subjects: Get full text

Quantitative systems modeling approaches towards model-informed drug development: Perspective through case studies by Meghna Verma, Louis Gall, Jacopo Biasetti, Giovanni Y. Di Veroli, Cesar Pichardo-Almarza, Megan A. Gibbs, Holly Kimko

Subjects: Get full text

Establishing a Relationship between In Vitro Potency in Cell-Based Assays and Clinical Efficacious Concentrations for Approved GLP-1 Receptor Agonists by Alessandro Boianelli, Pär Nordell, Joseph Earl, Jacqueline Naylor, David Hornigold, Rasmus Jansson Löfmark, Monika Sundqvist

Subjects: Get full text

Corrigendum: Mathematical modeling in autoimmune diseases: from theory to clinical application by Yaroslav Ugolkov, Yaroslav Ugolkov, Yaroslav Ugolkov, Antonina Nikitich, Antonina Nikitich, Cristina Leon, Gabriel Helmlinger, Kirill Peskov, Kirill Peskov, Kirill Peskov, Kirill Peskov, Victor Sokolov, Victor Sokolov, Alina Volkova, Alina Volkova

Subjects: Get full text

Model-Based Prediction of Acid Suppression and Proposal of a New Dosing Regimen of Fexuprazan in Humans by Min-Soo Kim, Nora Lee, Areum Lee, Yoon-Jee Chae, Suk-Jae Chung, Kyeong-Ryoon Lee

Subjects: Get full text

The emerging role of physiologically-based pharmacokinetic/biopharmaceutics modeling in formulation development by Cvijić Sandra, Ignjatović Jelisaveta, Parojčić Jelena, Ibrić Svetlana

Subjects: Get full text